Pro-dex ( (PDEX) ) has released its Q4 earnings. Here is a breakdown of the information Pro-dex presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pro-Dex, Inc. is a company specializing in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers primarily used in the orthopedic, thoracic, and maxocranial facial markets. The company is known for its patented adaptive torque-limiting software and proprietary sealing solutions, catering mainly to medical device distributors.
In its fiscal 2025 fourth quarter and full-year results, Pro-Dex reported a significant increase in net sales, driven by strong demand from its top customers. However, the company faced challenges with a decrease in gross profit and operating income for the quarter due to unfavorable product mix and higher manufacturing costs.
Key financial highlights for the year include a 24% increase in net sales to $66.6 million, primarily due to sales of the next-generation handpiece. Despite a challenging fourth quarter, the company achieved a 34% increase in gross profit for the year, with operating income rising by 49% to $10.7 million. Net income also saw a substantial increase to $9.0 million, buoyed by unrealized gains on marketable equity investments.
Looking ahead, Pro-Dex’s management remains optimistic about continued growth in revenue and operating income for fiscal 2026. The company is working on sharing tariff costs with customers and enhancing its manufacturing systems, supported by a strong backlog of $50.4 million as of June 30, 2025.